Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy

Peng Shan1 Department of Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People’s Republic of China;2 Core Unit of National Clinical Research Center for Laboratory Medicine, Hefei, Anhui, 230036, People’s Republic of China

https://orcid.org/0000-0002-4432-6008

Hang Dong1 Department of Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People’s Republic of China;2 Core Unit of National Clinical Research Center for Laboratory Medicine, Hefei, Anhui, 230036, People’s Republic of China

Shilan Li3 Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-1692-7404

References

Ber JGU. Mastzellenleukamien. Dtsch Arch Klin Med. 1906;87:437.
Google Scholar
Gupta R, Jain P, Anand M. Acute basophilic leukemia: case report. Am J Hematol. 2004;76(2):134–138. doi:10.1002/ajh.10446
PubMed Web of Science ®Google Scholar
Xu P, Zhang C, Wang Y, et al. Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation—the mast cell is an indicator of myeloid transformation. Transl Cancer Res. 2019;8(5):2121–2129. doi:10.21037/tcr.2019.09.29
PubMed Web of Science ®Google Scholar
Peterson LC, Parkin JL, Arthur DC, Brunning RD. Acute basophilic leukemia. A clinical, morphologic, and cytogenetic study of eight cases. Am J Clin Pathol. 1991;96(2):160–170. doi:10.1093/ajcp/96.2.160
PubMed Web of Science ®Google Scholar
Rojas-Atencio A, Urdaneta K, Soto-Quintana M, Alvarez Nava F, Canizales J, Solis E. Trisomy 19 and t(9;22) in a patient with acute basophilic leukemia. Case Rep Pathol. 2011;2011:269491. doi:10.1155/2011/269491
PubMedGoogle Scholar
Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol. 2022;97(9):1236–1256. doi:10.1002/ajh.26642
PubMed Web of Science ®Google Scholar
Di Maria S, Picarazzi F, Mori M, et al. Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment. Bioorg Chem. 2022;128:106071. doi:10.1016/j.bioorg.2022.106071
PubMed Web of Science ®Google Scholar

Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date